Here, we provide first evidence that, in GBM CSCs, NDRG1 is directly and negatively regulated by ASCL1, and, most importantly, that NDRG1 overexpression and silencing in CSCs enhances and decreases the MES phenotype, respectively. The gene discussed is NDRG1; the disease is glioblastoma.